Dive into the latest global developments, including psychedelic therapy's insurance coverage by Alberta Blue Cross, significant legal judgments against former U.S. President Trump, dire conditions in Gaza, and the technological aftermath of TikTok's ban in India. Discover the potential of AI in revolutionizing mental health support and conflict resolution, alongside key insights into the cannabis industry's evolution.

Stay Inspired, Stay Informed with The Daily Dose!

Join SykoActive Studios in exploring the future of health, technology, and well-being. Subscribe for insightful updates and be part of a community at the forefront of transformative healthcare trends.

The world of psychedelics and cannabis is witnessing a remarkable period of transformation. Advances in medical research, evolving legal landscapes, and growing investment interests are shaping a new frontier in health and wellness.

In an unprecedented move, Atai Life Sciences, a global biotech company, has invested a significant amount in Beckley Psytech, a company specializing in psychedelic medicine. This strategic investment marks a monumental step towards the development of rapid-acting psychedelic medicines, signifying a potential paradigm shift in mental health treatment.

The landscape of drug policy in the United States is undergoing a seismic shift, and California's AB-1021 is at the epicenter. The bill, part of the 2023-2024 legislative session, challenges long-standing perceptions of several Schedule 1 drugs, including heroin, LSD, cannabis, methaqualone, peyote, and notably, psychedelics like MDMA and psilocybin.

Methaqualone's rise and fall in popularity are quite intriguing. As you mentioned, it was initially synthesized in India in the 1950s and later introduced into the United States in the 1960s. Now being considered decriminalized in 2024!

In a significant policy shift, California has made strides towards the decriminalization of certain psychedelic drugs. Governor Gavin Newsom's recent ratification of the legislation marks a pivotal moment in the state's approach to drug policy and mental health treatment.

With The regulatory framework of measure 109 now in place, the start of 2023 means that Oregon is beginning to accept applications for licenses to operate in the new psychedelic industry.

Enthea, a provider of psychedelic healthcare insurance plans, declared that it will expand its services into 40 markets across the US in 2023 with the goal of making workplace benefits for psychedelic-assisted therapies reasonable, equitable, and available.

Colorado Votes on Decriminalizing the Possession, Storing, Using, Processing, Transporting, Purchasing, Obtaining, or INGESTING NATURAL MEDICINE FOR PERSONAL USE AND EVEN GIVING AWAY NATURAL MEDICINE FOR PERSONAL USE WITHOUT REMUNERATION TO A PERSON OR PERSONS TWENTY-ONE YEARS OF AGE OR OLDER!

Senator Scott Wiener’s Senate Bill 519, which decriminalizes the possession and personal use of certain psychedelic drugs will be voted on next year. San Francisco Supervisors Dean Preston and Hillary Ronen introduced legislation that would decriminalize use and possession of psilocybin mushrooms, LSD, MDMA, DMT, and Mescaline.

The Drug Enforcement Administration has reversed its decision to the scheduling proposal that would have placed five tryptamine hallucinogens, as identified in this proposed rule, in schedule I of the Controlled Substances Act.

In partnership with the newly founded Center for Psychedelic Drug Research and Education at The Ohio State University, Psychedemia 2022 will provide a rigorous interdisciplinary symposium for exchanging ideas, evaluating dominant perspectives, and critiquing current approaches to developing social frameworks for psychedelic use.

Awakn Life Sciences Corp. , a psychedelic biotechnology company focused on researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder, has announced on June 2nd that they have initiated a larger behavioral addiction study investigating ketamine as a treatment for Gambling Disorder.

A Maryland House of Delegates Committee recently held a hearing on creating a psychedelics access fund. The Post-Traumatic Stress Disorder and Traumatic Brain Injury Alternative Therapies Fund could give Maryland’s veterans access to psychedelics like psilocybin, MDMA, and ketamine to help them find relief.

Today the hot news is that Ecstasy and psilocybin are shaking up psychiatry with psychedelic Therapy Schools Popping Up everywhere like little Magic Mushrooms! In addition to recently announced Hawaii, New Psychedelic Bills are being filed in Florida, Connecticut, Vermont and New Jersey, as the freedom of consciousness and natural medicine movement sweeps the globe.

Despite thousands of years of shamanic psychological clinical trials in the wild, leading to profound revelations of apex love elevations beyond the mind of space and time. Modern scientific research is finally caching up. And we are on the verge of tapping into the extensive healing potential of ENTHEOGENS such as Mother Ayahuasca, DMT, Psilocybin Magic Mushrooms, Sassafras MDMA, LSD, Wily Coyote Peyote and the many other sacred plants recently decriminalized in the great American Cities of Denver, Colorado, Oakland, Santa Cruz California, the Great State of Oregon and the capital itself, Washington DC.

The latest states to join us on our quest for consciousness freedom are Florida and New Jersey, who have taken the next steps in clinical trials of entheogens. Oregon also just officially decriminalized all drugs and replaced jail time with a $100 fine for public possession or intoxication, along with a health assessment for addiction and mental health issues, which seems like a healthier step in the right direction.

In the past 12 months, Cybin has expanded the psychedelic organization to more than 55 employees across four countries and has established partnerships with over 50 participants in the psychedelic industry.